Heterozygote Wdr36-deficient mice do not develop glaucoma

Experimental Eye Research

Volumn 128, Issue , 2014, Pages 83-91

  Gallenberger, Martin ^a   Kroeber, Markus ^a   März, Loreen ^a   Koch, Marcus ^a   Fuchshofer, Rudolf ^a   Braunger, Barbara M ^a   Iwata, Takeshi ^b   Tamm, Ernst R ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

Author keywords

Animal model; Genetics; Primary open angle glaucoma

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID; NUCLEAR PROTEIN; RNA 18S; UNCLASSIFIED DRUG; WDR36 PRTOEIN; EYE PROTEIN; MESSENGER RNA; N METHYLASPARTIC ACID; WDR36 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ARTICLE; BLASTOCYST; ELECTRON MICROSCOPY; EXCITOTOXICITY; GENETIC DISORDER; GENETIC VARIABILITY; HETEROZYGOTE; INTRAOCULAR PRESSURE; MOUSE; MOUSE EMBRYO; NONHUMAN; OPEN ANGLE GLAUCOMA; OPTIC NERVE INJURY; PHENOTYPE; RETINA GANGLION CELL; RETINA INJURY; RNA ISOLATION; ALLELE; ANIMAL; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HETEROZYGOSITY LOSS; NERVE FIBER; NORTHERN BLOTTING; OCULOPLETHYSMOGRAPHY; OPTIC NERVE DISEASE; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; TOXICITY; TRANSGENIC MOUSE;

ALLELES; ANIMALS; AXONS; BLOTTING, NORTHERN; DISEASE MODELS, ANIMAL; EYE PROTEINS; GENE EXPRESSION REGULATION; GLAUCOMA, OPEN-ANGLE; INTRAOCULAR PRESSURE; LOSS OF HETEROZYGOSITY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; N-METHYLASPARTATE; OPTIC NERVE DISEASES; PHENOTYPE; REAL-TIME POLYMERASE CHAIN REACTION; RETINAL GANGLION CELLS; RISK FACTORS; RNA, MESSENGER; TONOMETRY, OCULAR;

EID: 84907876943     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2014.09.008     Document Type: Article

References (54)

1. Barlow J.L., Drynan L.F., Hewett D.R., Holmes L.R., Lorenzo-Abalde S., Lane A.L., Jolin H.E., Pannell R., Middleton A.J., Wong S.H., Warren A.J., Wainscoat J.S., Boultwood J., McKenzie A.N. Ap53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome. Nat. Med. 2010, 16:59-66.
2. Bernstein K.A., Gallagher J.E., Mitchell B.M., Granneman S., Baserga S.J. The small-subunit processome is a ribosome assembly intermediate. Eukaryot. Cell. 2004, 3:1619-1626.
3. Blanco-Marchite C., Sanchez-Sanchez F., Lopez-Garrido M.P., Inigez-de-Onzono M., Lopez-Martinez F., Lopez-Sanchez E., Alvarez L., Rodriguez-Calvo P.P., Mendez-Hernandez C., Fernandez-Vega L., Garcia-Sanchez J., Coca-Prados M., Garcia-Feijoo J., Escribano J. WDR36 and P53 gene variants and susceptibility to primary open-angle glaucoma: analysis of gene-gene interactions. Invest. Ophthalmol. Vis. Sci. 2011, 52:8467-8478.
4. Chakraborty A., Uechi T., Kenmochi N. Guarding the 'translation apparatus': defective ribosome biogenesis and the p53 signaling pathway. Wiley Interdiscip. Rev. RNA 2011, 2:507-522.
5. Chen H., Li Z., Haruna K., Semba K., Araki M., Yamamura K., Araki K. Early pre-implantation lethality in mice carrying truncated mutation in the RNA polymerase 1-2 gene. Biochem.. Biophys. Res. Commun. 2008, 365:636-642.
6. Chi Z.L., Yasumoto F., Sergeev Y., Minami M., Obazawa M., Kimura I., Takada Y., Iwata T. Mutant WDR36 directly affects axon growth of retinal ganglion cells leading to progressive retinal degeneration in mice. Hum. Mol. Genet. 2010, 19:3806-3815.
7. Collaborative Normal-Tension Glaucoma Study Group Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am. J. Ophthalmol. 1998, 126:487-497.
8. Collaborative Normal-Tension Glaucoma Study Group The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group. Am. J. Ophthalmol. 1998, 126:498-505.
9. Fan B.J., Wang D.Y., Cheng C.Y., Ko W.C., Lam S.C., Pang C.P. Different WDR36 mutation pattern in Chinese patients with primary open-angle glaucoma. Mol. Vis. 2009, 15:646-653.
10. Fan B.J., Wiggs J.L. Glaucoma: genes, phenotypes, and new directions for therapy. J.Clin. Invest 2011, 120:3064-3072.
11. Fingert J.H. Primary open-angle glaucoma genes. Eye (Lond.) 2011, 25:587-595.
12. Fingert J.H., Alward W.L., Kwon Y.H., Shankar S.P., Andorf J.L., Mackey D.A., Sheffield V.C., Stone E.M. No association between variations in the WDR36 gene and primary open-angle glaucoma. Arch. Ophthalmol. 2007, 125:434-436.
13. Fingert J.H., Robin A.L., Stone J.L., Roos B.R., Davis L.K., Scheetz T.E., Bennett S.R., Wassink T.H., Kwon Y.H., Alward W.L., Mullins R.F., Sheffield V.C., Stone E.M. Copy number variations on chromosome 12q14 in patients with normal tension glaucoma. Hum. Mol. Genet. 2011, 20:2482-2494.
14. Footz T.K., Johnson J.L., Dubois S., Boivin N., Raymond V., Walter M.A. Glaucoma-associated WDR36 variants encode functional defects in a yeast model system. Hum. Mol. Genet. 2009, 18:1276-1287.
15. Freed E.F., Bleichert F., Dutca L.M., Baserga S.J. When ribosomes go bad: diseases of ribosome biogenesis. Mol. Biosyst. 2010, 6:481-493.
16. Fumagalli S., Thomas G. The role of p53 in ribosomopathies. Semin. Hematol. 2011, 48:97-105.
17. Gallenberger M., Meinel D.M., Kroeber M., Wegner M., Milkereit P., Bösl M.R., Tamm E.R. Lack of WDR36 leads to preimplantation embryonic lethality in mice and delays the formation of small subunit ribosomal RNA in human cells invitro. Hum. Mol. Genet. 2011, 20:422-435.
18. Hauser M.A., Allingham R.R., Linkroum K., Wang J., LaRocque-Abramson K., Figueiredo D., Santiago-Turla C., del Bono E.A., Haines J.L., Pericak-Vance M.A., Wiggs J.L. Distribution of WDR36 DNA sequence variants in patients with primary open-angle glaucoma. Invest. Ophthalmol. Vis. Sci. 2006, 47:2542-2546.
19. Hewitt A.W., Dimasi D.P., Mackey D.A., Craig J.E. Aglaucoma case-control study of the WDR36 gene D658G sequence variant. Am. J. Ophthalmol. 2006, 142:324-325.
20. Higginbotham E.J., Gordon M.O., Beiser J.A., Drake M.V., Bennett G.R., Wilson M.R., Kass M.A. The ocular hypertension treatment study: topical medication delays or prevents primary open-angle glaucoma in African American individuals. Arch. Ophthalmol. 2004, 122:813-820.
21. Johnson M. What controls aqueous humour outflow resistance?. Exp. Eye Res. 2006, 82:545-557.
22. Junglas B., Kuespert S., Seleem A.A., Struller T., Ullmann S., Bosl M., Bosserhoff A., Kostler J., Wagner R., Tamm E.R., Fuchshofer R. Connective tissue growth factor causes glaucoma by modifying the actin cytoskeleton of the trabecular meshwork. Am. J. Pathol. 2012, 180:2386-2403.
23. Karnovsky M.J. Aformaldehyde-glutaraldehyde fixative of high osmolality for use in electron-microscopy. J.Cell. Biol. 1965, 27:137-138.
24. Kass M.A., Heuer D.K., Higginbotham E.J., Johnson C.A., Keltner J.L., Miller J.P., Parrish R.K., Wilson M.R., Gordon M.O. The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch. Ophthalmol. 2002, 120:701-713. discussion 829-730.
25. Kramer P.L., Samples J.R., Monemi S., Sykes R., Sarfarazi M., Wirtz M.K. The role of the WDR36 gene on chromosome 5q22.1 in a large family with primary open-angle glaucoma mapped to this region. Arch. Ophthalmol. 2006, 124:1328-1331.
26. Kressler D., Hurt E., Bassler J. Driving ribosome assembly. Biochim. Biophys. Acta 2010, 1803:673-683.
27. Kroeber M., Davis N., Holzmann S., Kritzenberger M., Shelah-Goraly M., Ofri R., Ashery-Padan R., Tamm E.R. Reduced expression of Pax6 in lens and cornea of mutant mice leads to failure of chamber angle development and juvenile glaucoma. Hum. Mol. Genet. 2010, 19:3332-3342.
28. Kwon Y.H., Fingert J.H., Kuehn M.H., Alward W.L. Primary open-angle glaucoma. N.Engl. J. Med. 2009, 360:1113-1124.
29. Lerch-Gaggl A., Haque J., Li J., Ning G., Traktman P., Duncan S.A. Pescadillo is essential for nucleolar assembly, ribosome biogenesis, and mammalian cell proliferation. J.Biol. Chem. 2002, 277:45347-45355.
30. Leske M.C., Heijl A., Hussein M., Bengtsson B., Hyman L., Komaroff E. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch. Ophthalmol. 2003, 121:48-56.
31. Liu Y., Allingham R.R. Molecular genetics in glaucoma. Exp. Eye. Res. 2011, 93:331-339.
32. Matsson H., Davey E.J., Draptchinskaia N., Hamaguchi I., Ooka A., Leveen P., Forsberg E., Karlsson S., Dahl N. Targeted disruption of the ribosomal protein S19 gene is lethal prior to implantation. Mol. Cell. Biol. 2004, 24:4032-4037.
33. McGowan K.A., Mason P.J. Animal models of Diamond Blackfan anemia. Semin. Hematol. 2011, 48:106-116.
34. Miyazawa A., Fuse N., Mengkegale M., Ryu M., Seimiya M., Wada Y., Nishida K. Association between primary open-angle glaucoma and WDR36 DNA sequence variants in Japanese. Mol. Vis. 2007, 13:1912-1919.
35. Monemi S., Spaeth G., DaSilva A., Popinchalk S., Ilitchev E., Liebmann J., Ritch R., Heon E., Crick R.P., Child A., Sarfarazi M. Identification of a novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22.1. Hum. Mol. Genet. 2005, 14:725-733.
36. Morrison R.S., Kinoshita Y., Johnson M.D., Guo W., Garden G.A. p53-dependent cell death signaling in neurons. Neurochem.. Res. 2003, 28:15-27.
37. Narla A., Ebert B.L. Ribosomopathies: human disorders of ribosome dysfunction. Blood 2010, 115:3196-3205.
38. Newton K., Petfalski E., Tollervey D., Caceres J.F. Fibrillarin is essential for early development and required for accumulation of an intron-encoded small nucleolar RNA in the mouse. Mol. Cell. Biol. 2003, 23:8519-8527.
39. Okabe M., Ikawa M., Kominami K., Nakanishi T., Nishimune Y. 'Green mice' as a source of ubiquitous green cells. FEBS Lett. 1997, 407:313-319.
40. Pang C.P., Fan B.J., Canlas O., Wang D.Y., Dubois S., Tam P.O., Lam D.S., Raymond V., Ritch R. Agenome-wide scan maps a novel juvenile-onset primary open angle glaucoma locus to chromosome 5q. Mol. Vis. 2006, 12:85-92.
41. Pasutto F., Mardin C.Y., Michels-Rautenstrauss K., Weber B.H., Sticht H., Chavarria-Soley G., Rautenstrauss B., Kruse F., Reis A. Profiling of WDR36 missense variants in German patients with glaucoma. Invest. Ophthalmol. Vis. Sci. 2008, 49:270-274.
42. Pasutto F., Matsumoto T., Mardin C.Y., Sticht H., Brandstatter J.H., Michels-Rautenstrauss K., Weisschuh N., Gramer E., Ramdas W.D., van Koolwijk L.M., Klaver C.C., Vingerling J.R., Weber B.H., Kruse F.E., Rautenstrauss B., Barde Y.A., Reis A. Heterozygous NTF4 mutations impairing neurotrophin-4 signaling in patients with primary open-angle glaucoma. Am. J. Hum. Genet. 2009, 85:447-456.
43. Quigley H.A. Glaucoma. Lancet 2011, 377:1367-1377.
44. Rezaie T., Child A., Hitchings R., Brice G., Miller L., Coca-Prados M., Heon E., Krupin T., Ritch R., Kreutzer D., Crick R.P., Sarfarazi M. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 2002, 295:1077-1079.
45. Richardson K.C., Jarret L., Finke H. Embedding in epoxy resins for ultrathin sectioning in electron microscopy. Stain Technol. 1960, 35:313-323.
46. Romanova L.G., Anger M., Zatsepina O.V., Schultz R.M. Implication of nucleolar protein SURF6 in ribosome biogenesis and preimplantation mouse development. Biol. Reprod. 2006, 75:690-696.
47. Schultze W.H. Über das Paraphenylendiamin in der histologischen Färbetechnik und über eine neue Schnellfärbemethode der Nervenmarkscheide am Gefrierschnitt. Zentralbl. Pathol 1972, 36:639-640.
48. Seitz R., Tamm E.R. N-methyl-D-aspartate (NMDA)-mediated excitotoxic damage: a mouse model of acute retinal ganglion cell damage. Methods Mol. Biol. 2013, 935:99-109.
49. Skarie J.M., Link B.A. The primary open-angle glaucoma gene WDR36 functions in ribosomal RNA processing and interacts with the p53 stress-response pathway. Hum. Mol. Genet. 2008, 17:2474-2485.
50. Stone E.M., Fingert J.H., Alward W.L.M., Nguyen T.D., Polansky J.R., Sunden S.L.F., Nishimura D., Clark A.F., Nystuen A., Nichols B.E., Mackey D.A., Ritch R., Kalenak J.W., Craven E.R., Sheffield V.C. Identification of a gene that causes primary open angle glaucoma. Science 1997, 275:668-670.
51. Tamm E.R., Toris C.B., Crowston J.G., Sit A., Lim S., Lambrou G., Alm A. Basic science of intraocular pressure. Intraocular Pressure. Reports and Consensus Statements of the 4th Global AIGS Consensus Meeting on Intraocular Pressure 2007, 1-14. Kugler Publications, Amsterdam. R.N. Weinreb, J.D. Brandt, D. Garway-Heath, F. Medeiros (Eds.).
52. The AGIS Investigators The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am. J. Ophthalmol. 2000, 130:429-440.
53. Weisschuh N., Wolf C., Wissinger B., Gramer E. Variations in the WDR36 gene in German patients with normal tension glaucoma. Mol. Vis. 2007, 13:724-729.
54. Zhang J., Tomasini A.J., Mayer A.N. RBM19 is essential for preimplantation development in the mouse. BMC Dev. Biol. 2008, 8:115.